SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 21,204.42 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 2,778,164.00 |
| Book Value / Share | 5,172.60 |
| Price / Book | n/a |
| NCAV ($M) | 405,885.00 |
| NCAV / Share | 755.71 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.12 |
| Return on Assets (ROA) | 0.10 |
| Return on Equity (ROE) | 0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.69 |
| Current Ratio | 2.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,366,972.00 |
| Assets | 3,739,251.00 |
| Liabilities | 961,087.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,329,861.00 |
| Operating Income | 417,911.00 |
| Net Income | 343,120.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 354,638.00 |
| Cash from Investing | -265,793.00 |
| Cash from Financing | -189,367.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| OPHLF – Ono Pharmaceutical Co., Ltd. | ORGS – Orgenesis Inc. |
| OTLC – Oncotelic Therapeutics, Inc. | OVIT – OncoVista Innovative Therapies, Inc. |
| OWPC – One World Products, Inc. |
Financial data and stock pages provided by
Fintel.io